PCP
ALNY icon

Proficio Capital Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Proficio Capital Partners’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
+919
New +$277K 0.01% 526
2025
Q4 		– Sell
-488
Closed -$223K – 241
2025
Q3 		$223K Sell
488
-394
-45% -$160K 0.02% 210
2025
Q2 		$288K Buy
882
+74
+9% +$20.5K 0.02% 328
2025
Q1 		$218K Buy
+808
New +$208K 0.02% 354
2024
Q4 		– Sell
-744
Closed -$205K – 365
2024
Q3 		$205K Sell
744
-838
-53% -$218K 0.02% 271
2024
Q2 		$384K Sell
1,582
-464
-23% -$73.3K 0.04% 203
2024
Q1 		$306K Buy
+2,046
New +$341K 0.03% 240
2019
Q3 		– Sell
-74
Closed -$5K – 188
2019
Q2 		$5K Sell
74
-4
-5% -$307 ﹤0.01% 1183
2019
Q1 		$7K Buy
78
+2
+3% +$167 ﹤0.01% 987
2018
Q4 		$6K Sell
76
-26
-25% -$2K ﹤0.01% 814
2018
Q3 		$9K Hold
102
– – ﹤0.01% 817
2018
Q2 		$10K Buy
102
+40
+65% +$3.97K ﹤0.01% 817
2018
Q1 		$7K Buy
62
+24
+63% +$3.09K ﹤0.01% 910
2017
Q4 		$5K Hold
38
– – ﹤0.01% 955
2017
Q3 		$4K Hold
38
– – ﹤0.01% 976
2017
Q2 		$3K Hold
38
– – ﹤0.01% 1022
2017
Q1 		$3K Buy
38
+7
+23% +$324 ﹤0.01% 1053
2016
Q4 		$1K Sell
31
-20
-39% -$837 ﹤0.01% 983
2016
Q3 		$3K Buy
51
+45
+750% +$3.17K ﹤0.01% 795
2016
Q2 		$0 Buy
+6
New +$378 ﹤0.01% 1007
2016
Q1 		– Sell
-13
Closed -$1K – 1043
2015
Q4 		$1K Buy
+13
New +$1.21K ﹤0.01% 744

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Proficio Capital Partners's ALNY Position: Q2 2026 in Review

Proficio Capital Partners opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 919 shares worth $277K. The stake represents 0.01% of the portfolio and ranks #526 among its holdings. This is a return to the name: Proficio Capital Partners previously reported a position in ALNY as recently as Q3 2025.

Proficio Capital Partners first reported a position in ALNY in Q4 2015 and has held it in 21 quarters since. The position peaked at $384K in Q2 2024. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Proficio Capital Partners held 919 shares of Alnylam Pharmaceuticals worth $277K as of Q2 2026.
  • Alnylam Pharmaceuticals was a new Proficio Capital Partners position in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Proficio Capital Partners's portfolio in Q2 2026, its #526 holding.
  • Proficio Capital Partners first reported a position in Alnylam Pharmaceuticals in Q4 2015 and has held it in 21 quarters since.
  • Proficio Capital Partners's Alnylam Pharmaceuticals position peaked at $384K in Q2 2024.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Proficio Capital Partners's 13F filing for Q2 2026, filed 17 Aug 2026.